SAN DIEGO, July 15, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced results from a new analysis using real-world data from CAHtalog ®, a comprehensive registry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results